Medicine and Dentistry
Non Muscle Invasive Bladder Cancer
100%
Recurrent Disease
100%
Detrusor Muscle
83%
Mitomycin
83%
Hazard Ratio
66%
Transurethral Resection
50%
Bladder Tumor
50%
Bladder Cancer
50%
Recurrence Risk
33%
National Health Service
33%
Outcome Assessment
16%
Cancer Growth
16%
Cancer Recurrence
16%
Malignant Neoplasm
16%
Progression Free Survival
16%
Pharmacology, Toxicology and Pharmaceutical Science
Non Muscle Invasive Bladder Cancer
100%
Recurrent Disease
100%
Mitomycin
83%
Bladder Cancer
50%
Bladder Tumor
50%
Recurrence Risk
33%
Cancer Growth
16%
Malignant Neoplasm
16%
Progression Free Survival
16%
Cancer Recurrence
16%